324
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Ebselen suitably interacts with the potential SARS-CoV-2 targets: an in-silico approach

, ORCID Icon, , &
Pages 12286-12301 | Received 12 May 2021, Accepted 13 Aug 2021, Published online: 30 Aug 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (3)

Yifu Cheng, Guangchen Li, Luchen Jiang, Yunyi Dong, Xiangyu Zhan, Fengxia Sun & Yunfei Du. (2022) Construction of C-S and C-Se Bonds Mediated by Hypervalent Iodine Reagents Under Metal-Free Conditions. Current Organic Chemistry 26:21, pages 1935-1953.
Crossref
Haresh S. Kalasariya, Nikunj B. Patel, Amel Gacem, Taghreed Alsufyani, Lisa M. Reece, Virendra Kumar Yadav, Nasser S. Awwad, Hala A. Ibrahium, Yongtae Ahn, Krishna Kumar Yadav & Byong-Hun Jeon. (2022) Marine Alga Ulva fasciata-Derived Molecules for the Potential Treatment of SARS-CoV-2: An In Silico Approach. Marine Drugs 20:9, pages 586.
Crossref
Ahmed Boufissiou, Mohnad Abdalla, Mohamed Sharaf, Saud I. Al-Resayes, Kadi Imededdine, Mahboob Alam, Sakina Yagi, Mohammad Azam & Mohamed Yousfi. (2022) In-silico investigation of phenolic compounds from leaves of Phillyrea angustifolia L. as a potential inhibitor against the SARS-CoV-2 main protease (Mpro PDB ID:5R83) using a virtual screening method. Journal of Saudi Chemical Society 26:3, pages 101473.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.